Seung Taek Lim

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Positive Breast Cancer

Neoadjuvant Chemotherapy

Top Venues

Journal of breast cancer

Annals of surgical treatment and research

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Jean Schneider, Ye Won Jeon, Young Jin Suh, Seung Taek Lim
Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer. International journal of molecular sciences 23 (5) (2022)
Kwang-Min Kim, Hyang Suk Choi, Hany Noh, In-Jeong Cho, Seung Taek Lim, Jong-In Lee, Airi Han
Neutrophil to Lymphocyte Ratio after Treatment Completion as a Potential Predictor of Survival in Patients with Triple-Negative Breast Cancer. Journal of breast cancer 24 (5) (2021)
Ye Won Jeon, Seung Taek Lim, Hongki Gwak, Seon Young Park, Juhee Shin, Hye Sug Han, Young Jin Suh
Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy. Annals of surgical treatment and research 100 (2) (2021)
Jean Schneider, Hyouk Jin Lee, Seok-Jin Nam, Soo Jung Lee, Jin Hyang Jung, Sung Hoo Jung, Seung Taek Lim, Ye Won Jeon, Hongki Gwak
Relative Survival Benefit by Hormonal Receptor Status of Adding Trastuzumab to Neoadjuvant Chemotherapy in Breast Cancer Patients. Journal of breast cancer 23 (3) (2020)
Ye Won Jeon, Seung Taek Lim, Hongki Gwak, Seon Young Park, Young Jin Suh
Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy. Journal of breast cancer 23 (5) (2020)
Seung Taek Lim, Ye Won Jeon, Hongki Gwak, Young Jin Suh
Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer. Journal of breast cancer 23 (5) (2020)